Skip to main content
Livermore
Livermore
ZHEN

Brandywine Managers, LLC

SEC CIK
0001135121
Latest filing
Aug 13, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Brandywine Managers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
2,318
Value
$697.8K
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Brandywine Managers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,318$697.8K0.3%−850−26.8%ReducedHolders
Q1 20263,168$1.05M0.6%−450−12.4%ReducedHolders
Q4 20253,618$1.44M0.7%−100−2.7%ReducedHolders
Q3 20253,718$1.70M1.6%−500−11.9%ReducedHolders
Q2 20254,218$1.38M1.4%−130−3.0%ReducedHolders
Q1 20254,348$1.17M1.4%00.0%UnchangedHolders
Q4 20244,348$1.02M1.1%00.0%UnchangedHolders
Q3 20244,348$1.20M1.3%00.0%UnchangedHolders
Q2 20244,348$1.06M1.1%00.0%UnchangedHolders
Q1 20244,348$649.8K0.6%00.0%UnchangedHolders
Q4 20234,348$832.3K0.9%−260−5.6%ReducedHolders
Q3 20234,608$816.1K1.4%00.0%UnchangedHolders
Q2 20234,608$875.2K0.6%00.0%UnchangedHolders
Q1 20234,608$923.1K0.7%00.0%UnchangedHolders
Q4 20224,608$1.10M3.8%00.0%UnchangedHolders
Q3 20224,608$922.0K3.0%00.0%UnchangedHolders
Q2 20224,608$672.0K1.6%00.0%UnchangedHolders
Q1 20224,608$752.0K1.3%00.0%UnchangedHolders
Q4 20214,608$781.0K0.9%00.0%UnchangedHolders
Q3 20214,608$870.0K0.9%00.0%UnchangedHolders
Q2 20214,608$781.0K0.9%00.0%UnchangedHolders
Q1 20214,608$651.0K0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.